Search

everythinglearnresearchcommunity

for

Search:↓

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Spironolactone is a promising alternative to antibiotics for treating acne in adult females.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

The compounds tested could potentially treat hair loss and alopecia.

Combining minoxidil and fibroblast growth factor is more effective for treating male hair loss than using either alone.

Early diagnosis of alopecia frontal fibrosante is crucial, but treatment remains controversial and varies.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The finasteride patch effectively treats hair loss by enhancing skin absorption.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Topical tofacitinib is effective and safe for treating alopecia areata.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

A new treatment for hair loss shows promise with fewer side effects.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Alefacept does not effectively treat severe alopecia areata.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.